DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ecromeximab
Ecromeximab
Tanibirumab (CUI C3490677) Add to Cart
Modifications to the Harmonized Tariff Schedule of the United States To
I Regulations
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
INN Working Document 05.179 Update December 2010
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
BIOTECHNOLOGY Presented by America’S Biopharmaceutical Research Companies
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Customs Tariff - Schedule
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Mai Muita in Acut Ca Uti on Muunni
Top View
Assessment of the Evolution of Cancer Treatment Therapies
Pharmaabkommen A1 E
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
Biotechnology Presented by America’S Biopharmaceutical Research Companies
Division of HEMATOLOGY/ ONCOLOGY
1494 More Zr 89 Monocolonal Antibody And
Customs Tariff - Schedule Xxi - 1
Targeting Selectins, Siglecs and Mammalian Glycans
WO 2017/096163 Al 8 June 2017 (08.06.2017) W P O P C T
(12) United States Patent (10) Patent No.: US 9,345,770 B2 Storkus Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
International Journal of Current Advanced Research
Oncology Drugs in the Pipeline
Protein-Polymer-Drug Conjugates Protein-Polymer-Wirkstoffkonjugate Conjugués De Médicament-Protéine-Polymère
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
(INN) for Biological and Biotechnological Substances
Medicines & Vaccines in Development for Cancer
Ep 3088005 A1
Assessment of the Evolution of Cancer Treatment Therapies
Oncology Drugs in the Pipeline
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Human BMPR1B Amino Acid Sequence